In our current analyses, we found that pyroptosis is significantly associated with the increased expression of multiple immune checkpoint factors in the melanoma microenvironment, such as PD-1/PD-L1, CTLA4, TIM3, LAG3, and immune activation-related molecules, including OX-40, CD40, and CD86. Here, TNFRSF4 is linked to melanoma.